Arcellx’s CMO gives an update on their BCMA program at the 2023 CAR-TCR Summit
- blonca9
- Aug 30, 2023
- 1 min read
Chris Heery describes the process relating to bridging therapy that enabled a partial clinical hold to lift.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.